The Effects of Pegylated Interferon Alpha-2a and Alpha-2b Therapy on Chromosomal Aberrations and Mitotic Index in Patients with Chronic Hepatitis B
dc.contributor.author | Akbas, Halit | |
dc.contributor.author | Yalcin, Kendal | |
dc.contributor.author | Isi, Hilmi | |
dc.contributor.author | Simsek, Selda | |
dc.contributor.author | Atay, Ahmet Engin | |
dc.contributor.author | Budak, Turgay | |
dc.date.accessioned | 2024-04-24T17:27:37Z | |
dc.date.available | 2024-04-24T17:27:37Z | |
dc.date.issued | 2012 | |
dc.department | Dicle Üniversitesi | en_US |
dc.description.abstract | Objective: We aimed to prospectively evaluate the effects of pegylated interferon alpha-2a and alpha-2b therapy on chromosomal aberrations and mitotic index in patients with chronic hepatitis B. Material and Methods: Fifty patients with chronic hepatitis B who underwent pegylated interferon alpha-2a or 2b therapy were evaluated for chromosomal aberrations and mitotic index before the treatment and at the end of 6 months of therapy. Results: Cytogenetic examinations revealed out that there was no significant difference between pre- and post-treatment frequencies of mitotic index and chromosomal aberrations. Conclusion: Interferon alpha-2a and alpha-2b therapy which is associated with common hematologic adverse effects has no significant cytogenetic effect. | en_US |
dc.identifier.doi | 10.5336/medsci.2011-26395 | |
dc.identifier.endpage | 1559 | en_US |
dc.identifier.issn | 1300-0292 | |
dc.identifier.issn | 2146-9040 | |
dc.identifier.issue | 6 | en_US |
dc.identifier.scopus | 2-s2.0-84868317546 | |
dc.identifier.scopusquality | Q4 | |
dc.identifier.startpage | 1554 | en_US |
dc.identifier.uri | https://doi.org/10.5336/medsci.2011-26395 | |
dc.identifier.uri | https://hdl.handle.net/11468/20091 | |
dc.identifier.volume | 32 | en_US |
dc.identifier.wos | WOS:000314145000009 | |
dc.identifier.wosquality | N/A | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.language.iso | en | en_US |
dc.publisher | Ortadogu Ad Pres & Publ Co | en_US |
dc.relation.ispartof | Turkiye Klinikleri Tip Bilimleri Dergisi | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Hepatitis B | en_US |
dc.subject | Interferon Alfa-2a | en_US |
dc.subject | Interferon Alfa-2b | en_US |
dc.subject | Chromosome Aberrations | en_US |
dc.subject | Mitotic Index | en_US |
dc.title | The Effects of Pegylated Interferon Alpha-2a and Alpha-2b Therapy on Chromosomal Aberrations and Mitotic Index in Patients with Chronic Hepatitis B | en_US |
dc.title | The Effects of Pegylated Interferon Alpha-2a and Alpha-2b Therapy on Chromosomal Aberrations and Mitotic Index in Patients with Chronic Hepatitis B | |
dc.type | Article | en_US |